Katharina M. Habenicht

Erlangen, BY, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

De novo and quiescent cGVHD are distinguishable in a prognostic biomarker panel.

De novo and quiescent cGVHD are distinguishable in a prognostic biomarker panel.

Journal: Frontiers in immunology
Published: December 03, 2025

Expansions of circulating plasmablasts producing commensal-reactive IgA antibodies are predictors for chronic GVHD.

Expansions of circulating plasmablasts producing commensal-reactive IgA antibodies are predictors for chronic GVHD.

Journal: Blood
Published: October 15, 2024

In vivo analysis of CRISPR-edited germinal center murine B cells.

In vivo analysis of CRISPR-edited germinal center murine B cells.

Journal: Frontiers in immunology
Published: July 31, 2024

Oligoclonal CD4+CXCR5+ T cells with a cytotoxic phenotype appear in tonsils and blood.

Oligoclonal CD4+CXCR5+ T cells with a cytotoxic phenotype appear in tonsils and blood.

Journal: Communications biology
Published: September 15, 2023

Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination.

Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination.

Journal: Science immunology
Published: December 22, 2022

Author Correction: Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus.

Author Correction: Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus.

Journal: Nature medicine
Published: November 04, 2022

Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus.

Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus.

Journal: Nature medicine
Published: July 04, 2022

A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model.

A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model.

Journal: European journal of immunology
Published: May 17, 2021

SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself.

SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself.

Journal: Nature communications
Published: September 24, 2020

Staphylococcus aureus Protein A Induces Human Regulatory T Cells Through Interaction With Antigen-Presenting Cells.

Staphylococcus aureus Protein A Induces Human Regulatory T Cells Through Interaction With Antigen-Presenting Cells.

Journal: Frontiers in immunology
Published: July 09, 2020
Showing 1-10 of 10

Last Updated: 09/26/2026